HBI Deals+Insights / M&A/IPOs
Brazilian health insurer Clinipam may be the target of four prospective buyers according to local reports – but the company denies it is for sale despite its apparent suitors. We speak to a Brazilian healthcare expert who tells us that Hapvida is the one to watch, and talk about its prospective targets and strategy.